Literature DB >> 26781464

COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species.

Jodie L Simpson1, Katherine J Baines1, Jay C Horvat1, Ama-Tawiah Essilfie1, Alexandra C Brown1, Melinda Tooze1, Vanessa M McDonald1,2, Peter G Gibson1,2, Philip M Hansbro1.   

Abstract

BACKGROUND AND
OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and inflammation. Airway bacterial colonization is increased in COPD; however, the role of potentially pathogenic and non-pathogenic bacteria in the pathogenesis of disease is unclear. This study characterized the presence of bacteria in a well-characterized cohort of adults with COPD and healthy controls.
METHODS: Adults with COPD (n = 70) and healthy controls (n = 51) underwent clinical assessment and sputum induction. Sputum was dispersed, and total and differential cell counts were performed. Bacteria were cultured, identified and enumerated. Supernatants were assessed for neutrophil elastase (NE) and IL-1β. Common respiratory pathogens were also determined using real-time PCR.
RESULTS: Participants with COPD had a typical neutrophilic inflammatory profile. The total load of bacteria was increased in COPD and was associated with poorer respiratory health status, as measured by the St George's Respiratory Questionnaire (Spearman's r = 0.336, P = 0.013). Significantly lower levels of culturable Bacillus species were identified compared with healthy controls. PCR analyses revealed increased rates of detection of potentially pathogenic bacteria with Haemophilus influenzae detection associated with higher sputum levels of NE and IL-1β, while Streptococcus pneumoniae was more common in male ex-smokers with emphysema and a deficit in diffusion capacity.
CONCLUSION: Non-pathogenic and pathogenic bacteria were altered in the sputum of patients with COPD. These observations highlight the potential to identify treatment and management strategies that both target specific bacterial pathogens and restore the microbial balance, which may lead to reductions in inflammation and subsequent improvements in lung health.
© 2016 Asian Pacific Society of Respirology.

Entities:  

Keywords:  bacteria; chronic obstructive pulmonary disease; inflammation; pathogen

Mesh:

Substances:

Year:  2016        PMID: 26781464     DOI: 10.1111/resp.12734

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  20 in total

1.  Boosting the IL-22 response using flagellin prevents bacterial infection in cigarette smoke-exposed mice.

Authors:  B Koné; M Pérez-Cruz; R Porte; F Hennegrave; C Carnoy; P Gosset; F Trottein; J-C Sirard; M Pichavant; P Gosset
Journal:  Clin Exp Immunol       Date:  2020-05-17       Impact factor: 4.330

2.  Why we need a vaccine for non-typeable Haemophilus influenzae.

Authors:  Marina Cerquetti; Maria Giufrè
Journal:  Hum Vaccin Immunother       Date:  2016-05-12       Impact factor: 3.452

Review 3.  Impact of Lung Microbiota on COPD.

Authors:  Cristina Russo; Valeria Colaianni; Giuseppe Ielo; Maria Stella Valle; Lucia Spicuzza; Lucia Malaguarnera
Journal:  Biomedicines       Date:  2022-06-06

4.  Impact of eosinophil-peroxidase (EPX) deficiency on eosinophil structure and function in mouse airways.

Authors:  Caroline M Percopo; Julia O Krumholz; Elizabeth R Fischer; Laura S Kraemer; Michelle Ma; Karen Laky; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2018-10-04       Impact factor: 4.962

5.  Potential clinical utility of multiple target quantitative polymerase chain reaction (qPCR) array to detect microbial pathogens in patients with chronic obstructive pulmonary disease (COPD).

Authors:  Hannah E O'Farrell; Janet G Shaw; Felicia Goh; Rayleen V Bowman; Kwun M Fong; Lutz Krause; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

6.  Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease.

Authors:  Hirofumi Kamata; Takanori Asakura; Shoji Suzuki; Ho Namkoong; Kazuma Yagi; Yohei Funatsu; Satoshi Okamori; Shunsuke Uno; Yoshifumi Uwamino; Hiroshi Fujiwara; Tomoyasu Nishimura; Makoto Ishii; Tomoko Betsuyaku; Naoki Hasegawa
Journal:  BMC Pulm Med       Date:  2017-12-13       Impact factor: 3.317

7.  Potential of Health and Demographic Surveillance System in Asthma and Chronic Obstructive Pulmonary Disease Microbiome Research.

Authors:  Dhiraj Agarwal; Dhiraj Dhotre; Rutuja Patil; Yogesh Shouche; Sanjay Juvekar; Sundeep Salvi
Journal:  Front Public Health       Date:  2017-08-04

8.  Toll-like receptor 2 and 4 have opposing roles in the pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease.

Authors:  Tatt Jhong Haw; Malcolm R Starkey; Stelios Pavlidis; Michael Fricker; Anya L Arthurs; Prema M Nair; Gang Liu; Irwan Hanish; Richard Y Kim; Paul S Foster; Jay C Horvat; Ian M Adcock; Philip M Hansbro
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-12       Impact factor: 5.464

9.  Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.

Authors:  Shih-Wei Lee; Chin-Sheng Kuan; Lawrence Shih-Hsin Wu; Julia Tzu-Ya Weng
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

Review 10.  Microbiome effects on immunity, health and disease in the lung.

Authors:  Shakti D Shukla; Kurtis F Budden; Rachael Neal; Philip M Hansbro
Journal:  Clin Transl Immunology       Date:  2017-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.